TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Improvement in attention/awareness-related outcomes (MAAS-A)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygen requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean dose of pregabalin
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: sitting time at work
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postoperative rises of NT-proBNP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: average daily sleep duration
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Cost saving from patients' perspective
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Costs/QALYs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: blastulation rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: grade of the embryo transferred
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: haematological toxicities GIII-IV
Endpoint domain: Adverse events/effects
Primary endpoint: Proportion of students eating breakfast
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of students eating lunch
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FACT-H&N total score change
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Overall symptom distress score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: wear time of thermoplastic retainer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pleurodesis failure at 90 days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to finish the first task with the polypropylene ball transfer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of errors during the needle grasping task
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Probability of completing the intracorporeal knot tying test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean electronic adherence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Neck circumference (cm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pittsburgh sleep quality index score
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Change in score after video-based learning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incremental cost per QALY gained
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Higher Order Aberrations (HOAs)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Culture conversion by Month 6
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Culture conversion by Month 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Respiratory treatment-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Reduction in monthly headache days
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Iron deficiency detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: SARS-CoV-2-neutralizing geometric mean titers
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence and severity of systemic reactions
Endpoint domain: Adverse events/effects
Primary endpoint: Change in mean weight relative to baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: AIS outcomes prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: decrease in sore throat
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: decrease in pharyngeal hyperemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Risk of incomplete response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rates of mental health diagnoses
Endpoint domain: Physiological/clinical
Endpoint subdomain: Mental health outcomes
Primary endpoint: Rates of specialist contacts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Mental health outcomes
Primary endpoint: motor inhibition
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of rectovaginal fistula
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of sexual intercourse per month
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Total Body Fat
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Metabolic Syndrome (MetSZ)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of CXR for TB detection
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Participation rate in screening
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Post cesarean pain relief
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Tafasitamab serum concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Median NK-cell counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Median B-cell counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Quality-adjusted life year (QALY) gained
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: TNF‐α levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: IL‐6 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: elbow strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Concentric velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Power (sets 1-3)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BSID-III cognitive scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: food responsiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: speed of food consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: rate of subsequent moderate injurious falls
Endpoint domain: Mortality/survival
Primary endpoint: VAS score of incision pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: VAS score of uterine contraction pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lactation score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Excess weight loss at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total weight loss at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-hatred
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: desire to stop future NSSI
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Low executive function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Efficacy against symptomatic VCD
Endpoint domain: Mortality/survival
Primary endpoint: Relative risk of hospitalization for VCD
Endpoint domain: Mortality/survival
Primary endpoint: Reduction in serum creatinine
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Reduction in oxygen supplementation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Mean percent APAP usage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average days of APAP machine utilization
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: APAP interface associated air leak
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time-to-first-event rates of any heart failure hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: time spent alive and out of the hospital
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: rates of fatal heart failure hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: FIT pick-up rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of CVR markers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Balance (BBS scores)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Functional mobility (TUG times)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: paternal and maternal depression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: emotion regulation using cognitive reappraisal
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: adolescent adjustment
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Reduction of ex vivo-stimulated IL-17A release
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: ≥50% improvement in EASI
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ≥3-point improvement in PP-NRS
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: ≥4-point improvement in DLQI
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: SF-36 Quality of Life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Incidence of food allergy episodes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Compliance with MyFood usage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Perceived harm of secondhand e‐cigarette exposure
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: change in end‐expiratory lung impedance (ΔEELI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: sputum mass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: clinical respiratory score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Adjusted mean difference in NCS, NPS, SNOT-22, TNSS, and UPSIT change from baseline
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Troponin levels postoperatively
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Proinflammatory cytokine levels (interleukin-6, interleukin-8, tumor necrosis factor)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Anti-inflammatory cytokine levels (interleukin-10)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: bleeding-related mortality
Endpoint domain: Mortality/survival
Primary endpoint: Death or HFH within 2 years
Endpoint domain: Mortality/survival
Primary endpoint: Functional outcomes (mRS 2-6)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of symptomatic ICH
Endpoint domain: Adverse events/effects
Primary endpoint: Achieved PASI90
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Bedsharing prevalence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of C acnes colonization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Decline in EGFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of moderately/severely impaired EGFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Reversion of moderately to mildly impaired GFR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Incidence of sports-related time-loss injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical decision-making scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: posttest urge ratings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: anterior elevation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Complete remission/complete remission with partial hematologic recovery rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: CCS scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: clinical judgment and counseling skills
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: medical interviewing skills and overall clinical competence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite of HF hospitalization or cardiovascular death
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: screening mammogram uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Feasibility and acceptability of BOLSTER intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: SIB score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Linkage to PrEP care within 3 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Initiation of PrEP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to linkage to PrEP care
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: cost per virally suppressed patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: cost per additional virally suppressed patient
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: cost-effectiveness over 20 years
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Clinical KSS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of PTSD severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in plaque around implants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: graft SNQ
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Recovery after resistance exercise
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: better physical functioning
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: greater mental QOL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Diabetic remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for extra narcotic analgesic drugs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Manual pressure requirement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: T-wave morphology
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Masseter thickness reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in hemoglobin A1c (HbA1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean blood leukocyte count
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: APACHE II index
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: audible sign of respiratory dysfunction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: GMFM-88
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: deficit accumulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Higher perseverance associated with orthorexic eating
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Higher negative affect associated with lower orthorexic eating
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: severity of radiodermatitis symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cotrimoxazole resistant bacteria incidence
Endpoint domain: Adverse events/effects
Primary endpoint: Healthy breakfast and snack consumption
Endpoint domain: Life impact
Endpoint subdomain: Nutrition
Primary endpoint: Hair growth and density
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area of hair loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: ARAT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: major venous and arterial thrombotic events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: time below range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Knee Injury and Osteoarthritis Outcome score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: squatting ability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment success rate for H. pylori eradication
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: balance and coordination scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall impression scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: final score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Loss of SAD diagnosis
Endpoint domain: Mortality/survival
Primary endpoint: Number of visits to a PCP
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of non-PCP visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: eradication rates of H pylori
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: non-vertebral fracture risk
Endpoint domain: Mortality/survival
Primary endpoint: clinical fracture risk
Endpoint domain: Mortality/survival
Primary endpoint: major osteoporotic fracture risk
Endpoint domain: Mortality/survival
Primary endpoint: mean time to surgical readiness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: SF-36 scores (bodily pain and physical role)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Plaque Index (ΔPI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Gingival Index (ΔmGI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Modified Sulcular Bleeding Index (ΔmSBI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Shear bond strength of H2SO4-etched PEEK to resin-matrix composite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Movement Imagery Questionnaire‐For Children (MIQ‐C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mental chronometry
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: resting muscle activation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Applicability of robotic surgery to T1 ovarian tumors
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Past 7-day tobacco abstinence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of good outcome following MT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parenchymal hemorrhage on follow-up imaging
Endpoint domain: Adverse events/effects
Primary endpoint: Hypertension control rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Urinary urgency and increased urinary frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of bacterial vaginosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: inspiratory tidal volume (iVt)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: expiratory tidal volume (eVt)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: chest dynamic compliance (Cdyn)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Catastrophic costs
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: OSFD-21
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: reduced added sugar in selected beverages
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: reduced calories in selected beverages
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes